Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors

Safety data on MET inhibitors in patients with advanced NSCLC harboring MET exon 14 mutation and treated with frontline immune checkpoint inhibitors (ICIs) are still limited. Here, we describe clinical characteristics, liver biopsy features, and management of liver injury of two patients with a diag...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Monia Sisi, MD, Giovanni Vitale, MD, PhD, Michele Fusaroli, MD, Mattia Riefolo, MD, Valentina Giunchi, BSc, Antonietta D’Errico, MD, Andrea Ardizzoni, MD, Emanuel Raschi, MD, PhD, Francesco Gelsomino, MD
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2023-09-01
coleção:	JTO Clinical and Research Reports
Assuntos:	MET inhibitors Immune checkpoint inhibitors Liver toxicity Drug-induced liver injury FDA Adverse Event Reporting System
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2666364323001066
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!